hhs_forecastForecastdd0bzz55p4z
RSAR: Post-marketing RX Drug Abuse Surveill Data Denver Health Data Source
Department of Health and Human Services.Food and Drug Administration.75F401.75F402
- Est. solicitation
- Jan 1, 2027
- Date posted
- —
- Source
- Open forecast
Description
The primary objective of this effort is for the FDA to obtain post-marketing data on NMU of prescription and over-the-counter drugs and use of illegal substances from individuals entering treatment centers or being assessed for treatment of substance use disorders.
Planning details
- Estimated value
- > $25K and < $250K
- Est. solicitation date
- Jan 1, 2027
- Anticipated award
- Mar 1, 2027
Classifications
- NAICS541990
- PSC541990